VEGFA and cancer: MSC-derived exosomes shuttled miR-16 [92] and miR-100 (inhibiting the mTOR/HIF-1α/VEGF pathway) [93] to the nearby cancer cells and decreased their VEGF expression, subsequently resulting in inhibition of the endothelial cells’ vascular behavior.